16886 Moyamoya-Like Vasculopathies Observed In a Novel Mouse Surgical Model

ABSTRACT IMPACT: Development of our animal model of moyamoya will provide a meaningful assessment of therapeutic efficacy of interventions applicable to the clinical setting. OBJECTIVES/GOALS: Moyamoya is a cerebrovascular condition with progressive stenosis of the internal carotid arteries (ICA) an...

Full description

Bibliographic Details
Main Authors: Justin F. Fraser, Laura Whitnel, Jill Roberts
Format: Article
Language:English
Published: Cambridge University Press 2021-03-01
Series:Journal of Clinical and Translational Science
Online Access:https://www.cambridge.org/core/product/identifier/S2059866121004581/type/journal_article
_version_ 1811155313799200768
author Justin F. Fraser
Laura Whitnel
Jill Roberts
author_facet Justin F. Fraser
Laura Whitnel
Jill Roberts
author_sort Justin F. Fraser
collection DOAJ
description ABSTRACT IMPACT: Development of our animal model of moyamoya will provide a meaningful assessment of therapeutic efficacy of interventions applicable to the clinical setting. OBJECTIVES/GOALS: Moyamoya is a cerebrovascular condition with progressive stenosis of the internal carotid arteries (ICA) and formation of abnormal vascular collaterals at the base of the brain, all of which result in ischemic and hemorrhagic strokes. We aim to develop a needed animal model of this condition in order to develop new therapeutics. METHODS/STUDY POPULATION: Male and female C57Bl/6J mice (4 months old) underwent surgery for the unilateral placement of a microcoil (0.16 mm ID) onto the proximal ICA or sham control. After 30 and 60 days (N = 6-8/time point), the brain blood vessels were examined for changes in diameter, number of anastomoses, and development of new collaterals using DiI stain. Brain tissue was examined for micro-hemorrhages using Prussian blue stain, and cross-sections of blood vessels were examined for intimal thickening using H&E and smooth muscle actin. Expression of vascular endothelial growth factor (VEGF), which is associated with angiogenesis and moyamoya syndrome, was quantified by qPCR. Blood samples were also analyzed for inflammatory biomarkers using ELISA. RESULTS/ANTICIPATED RESULTS: Within 30 days, the distal ICA and anterior cerebral artery (ACA) had significantly decreased diameters at the Circle of Willis, with an initial decrease in the number of cortical anastomoses. Histology demonstrated smaller lumen diameter and alterations to in the various layers of the blood vessels, indicating intimal thickening and stenosis of the affected blood vessels. There was also a significant increase in the number of intracranial micro-bleeds, suggesting a compromised vascular integrity. This may be due, in part, to a significant upregulation in VEGF gene expression within the striatum, a region of hemorrhagic occurrence in moyamoya patients. DISCUSSION/SIGNIFICANCE OF FINDINGS: We report the development of an animal model with vasculopathies that mimic those observed in patients with moyamoya syndrome. With further characterization, this animal model will have a positive impact as a meaningful assessment of therapeutic efficacy of interventions applicable to the clinical setting.
first_indexed 2024-04-10T04:32:11Z
format Article
id doaj.art-ca5969a287e64a9d9279fec4316adc1a
institution Directory Open Access Journal
issn 2059-8661
language English
last_indexed 2024-04-10T04:32:11Z
publishDate 2021-03-01
publisher Cambridge University Press
record_format Article
series Journal of Clinical and Translational Science
spelling doaj.art-ca5969a287e64a9d9279fec4316adc1a2023-03-10T07:52:03ZengCambridge University PressJournal of Clinical and Translational Science2059-86612021-03-015212110.1017/cts.2021.45816886 Moyamoya-Like Vasculopathies Observed In a Novel Mouse Surgical ModelJustin F. Fraser0Laura Whitnel1Jill Roberts2University of KentuckyUniversity of KentuckyUniversity of KentuckyABSTRACT IMPACT: Development of our animal model of moyamoya will provide a meaningful assessment of therapeutic efficacy of interventions applicable to the clinical setting. OBJECTIVES/GOALS: Moyamoya is a cerebrovascular condition with progressive stenosis of the internal carotid arteries (ICA) and formation of abnormal vascular collaterals at the base of the brain, all of which result in ischemic and hemorrhagic strokes. We aim to develop a needed animal model of this condition in order to develop new therapeutics. METHODS/STUDY POPULATION: Male and female C57Bl/6J mice (4 months old) underwent surgery for the unilateral placement of a microcoil (0.16 mm ID) onto the proximal ICA or sham control. After 30 and 60 days (N = 6-8/time point), the brain blood vessels were examined for changes in diameter, number of anastomoses, and development of new collaterals using DiI stain. Brain tissue was examined for micro-hemorrhages using Prussian blue stain, and cross-sections of blood vessels were examined for intimal thickening using H&E and smooth muscle actin. Expression of vascular endothelial growth factor (VEGF), which is associated with angiogenesis and moyamoya syndrome, was quantified by qPCR. Blood samples were also analyzed for inflammatory biomarkers using ELISA. RESULTS/ANTICIPATED RESULTS: Within 30 days, the distal ICA and anterior cerebral artery (ACA) had significantly decreased diameters at the Circle of Willis, with an initial decrease in the number of cortical anastomoses. Histology demonstrated smaller lumen diameter and alterations to in the various layers of the blood vessels, indicating intimal thickening and stenosis of the affected blood vessels. There was also a significant increase in the number of intracranial micro-bleeds, suggesting a compromised vascular integrity. This may be due, in part, to a significant upregulation in VEGF gene expression within the striatum, a region of hemorrhagic occurrence in moyamoya patients. DISCUSSION/SIGNIFICANCE OF FINDINGS: We report the development of an animal model with vasculopathies that mimic those observed in patients with moyamoya syndrome. With further characterization, this animal model will have a positive impact as a meaningful assessment of therapeutic efficacy of interventions applicable to the clinical setting.https://www.cambridge.org/core/product/identifier/S2059866121004581/type/journal_article
spellingShingle Justin F. Fraser
Laura Whitnel
Jill Roberts
16886 Moyamoya-Like Vasculopathies Observed In a Novel Mouse Surgical Model
Journal of Clinical and Translational Science
title 16886 Moyamoya-Like Vasculopathies Observed In a Novel Mouse Surgical Model
title_full 16886 Moyamoya-Like Vasculopathies Observed In a Novel Mouse Surgical Model
title_fullStr 16886 Moyamoya-Like Vasculopathies Observed In a Novel Mouse Surgical Model
title_full_unstemmed 16886 Moyamoya-Like Vasculopathies Observed In a Novel Mouse Surgical Model
title_short 16886 Moyamoya-Like Vasculopathies Observed In a Novel Mouse Surgical Model
title_sort 16886 moyamoya like vasculopathies observed in a novel mouse surgical model
url https://www.cambridge.org/core/product/identifier/S2059866121004581/type/journal_article
work_keys_str_mv AT justinffraser 16886moyamoyalikevasculopathiesobservedinanovelmousesurgicalmodel
AT laurawhitnel 16886moyamoyalikevasculopathiesobservedinanovelmousesurgicalmodel
AT jillroberts 16886moyamoyalikevasculopathiesobservedinanovelmousesurgicalmodel